All In MedTech

Device Trial Radar · NCT02378883

Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study

Last checked: Nov 20, 2026Latest source record: Apr 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

112

Actual

Start

May 18, 2015

Primary completion

Feb 20, 2018

Study completion Feb 20, 2018

Sponsor

Sponsor type
Industry
First posted
Mar 4, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety of the Apollo™ Onyx™ Delivery Microcatheter used for delivery of the Onyx™ Liquid Embolic System during brain arteriovenous malformation (AVM) embolization procedures.

Conditions

  • Arteriovenous Malformations

Interventions

  • Apollo™ Onyx™ Delivery Micro CatheterDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Catheter-related Adverse Events at 30 DaysTime frame: 30 days, after treatment with Onyx™ embolization using Apollo™ Onyx™ Delivery Microcatheter

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Radiology Imaging Associates, P.C.

    Englewood, Colorado

  • Brigham's & Women Hospital

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.